Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study

OBJECTIVES: Development of pharmaceutical agents in transplantation is currently limited by long waits for hard endpoints. We applied a validated integrative risk-prognostication system integrative Box (iBox) as a surrogate endpoint to the TRANSFORM Study, a large randomised controlled trial, to pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Aubert, Olivier, Divard, Gillian, Pascual, Julio, Oppenheimer, Federico, Sommerer, Claudia, Citterio, Franco, Tedesco, Helio, Chadban, Steve, Henry, Mitchell, Vincenti, Flavio, Srinivas, Titte, Watarai, Yoshihiko, Legendre, Christophe, Bernhardt, Peter, Loupy, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Renal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499283/
https://www.ncbi.nlm.nih.gov/pubmed/34620664
http://dx.doi.org/10.1136/bmjopen-2021-052138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499283/
https://www.ncbi.nlm.nih.gov/pubmed/34620664
http://dx.doi.org/10.1136/bmjopen-2021-052138

Ejemplares similares